Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
panobinostat
panobinostat
- Non-formulary Anti-Neoplastic Formulary
Last updated: Mar. 5, 2025
- Black Box Warning: Fatal and serious toxicities; severe diarrhea and cardiac toxicities
- HAZ-MED: Table 1
At Huntsville Main/W&C/Madison, orders for this medication should be rejected and reviewed by an oncology clinical specialist or an oncology pool member (see second page of the document "Hormone Therapies and Guidance on Oral Chemotherapy")
Withdrawn from the US market prior to January 2025.
Oral Chemotherapy Drug Pharmacist Education
Oral Chemotherapy TOC Information
Farydak medication guide
Farydak -- Oral drug used for treatment of resistant multiple myeloma, rare inpatient use expected. Non-formulary, not stocked, patient may use own supply in hospital.
Reviewed: 25 August 2015 (Farydak)
REMS (Farydak): View FDA REMS Info